Neurodegeneration – Products

New comprehensive biomarker panels equip physicians with clinically actionable insights for earlier, more accurate diagnosis.

Xavo, proudly announces Plexium as its latest esteemed client. - “We are thrilled to welcome Plexium to the Xavo family. The collaboration between the two companies marks a significant milestone in Xavo’s journey.

Consistent GMP-grade products are crucial as key raw materials for safe and reliable cell manufacturing. We adhere to stringent regulatory guidelines to provide high-quality GMP biomaterials for various cell culture and differentiation.

ioAstrocytes offer a solution to researchers who are searching for easy-to-use, highly characterised human cells that are designed for co-culture and effectively recapitulate astrocyte functions within CNS models in vitro

In this application note, researchers from Medicines Discovery Catapult (MDC) evaluated the suitability of iPSC-derived microglia as a model for studying the mechanics of microglia activation, shedding light on their role in neurodegeneration and the potential for therapeutic targets.

Pre-formed fibrils (PFFs) are novel tools for modeling neurodegenerative diseases in neuroscience research. Generated in vitro, these fibrils can imitate endogenous protein aggregation in both animal and cellular models, creating models that more closely resemble the “seeding” and “transmission” of pathogenic proteins observed in neurodegenerative diseases.

Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research.

This application note introduces an automated solution for flexible and sensitive multichannel analysis of neurite outgrowth for high-throughput assays.

Waters Xevo™ MRT Mass Spectrometer employs next-generation multi-reflecting time-of-flight technology to deliver class-leading combination of high resolution and speed without compromising analytical performance.

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based tissue imaging.